Evaluation of catecholamine metabolites, mIBG scan, and bone marrow cytology as response markers in stage 4 neuroblastoma
- 1 January 2001
- journal article
- clinical trial
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 36 (1) , 220-223
- https://doi.org/10.1002/1096-911x(20010101)36:1<220::aid-mpo1053>3.0.co;2-6
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- NeuroblastomPublished by Springer Nature ,1997
- A new 123I-MIBG whole body scan scoring method—Application to the prediction of the response of metastases to induction chemotherapy in stage IV neuroblastomaEuropean Journal Of Cancer, 1995
- Die Corticosteroid-abhängige Dezimierung der Leukämiezellzahl im Blut als Prognosefaktor bei der akuten lymphoblastischen Leukämie im Kindesalter (Therapiestudie ALL-BFM 83)Klinische Padiatrie, 1987
- Effect of age on homovanillic and 4-hydroxy-3-methoxymandelic acid levels in plasmaEuropean Journal of Pediatrics, 1986
- Mass fragmentographic determination of homovanillic and 4-hydroxy-3-methoxy mandelic acids in 50 μl plasmaClinica Chimica Acta; International Journal of Clinical Chemistry, 1983
- Clinical significance of catecholamine excretion levels in diagnosis and treatment of neuroblastoma.Archives of Disease in Childhood, 1975